Pharmaceutical Industry
By Beth GreenfieldOctober 2, 2024
By Ryan HoggSeptember 24, 2024
FinanceNovo Nordisk’s $570 billion valuation is more than Denmark’s GDP—but PM isn’t worried about a ‘Nokia risk’
By Sara Sjolin, Sanne Wass, Oliver Crook and BloombergSeptember 23, 2024
By Lindsey LeakeSeptember 21, 2024
LeadershipMark Cuban says he’s not going through a midlife crisis but would buy X and Fox News if he could
By Sydney LakeSeptember 16, 2024
NewslettersEli Lilly’s new CFO is a 23-year company veteran—showing how pharma firms rely on a ‘deep bench of qualified talent’
By Sheryl EstradaSeptember 10, 2024
CommentaryAging is the inflation of life. An emerging crop of longevity biotech companies needs investment to beat it
By Alex ZhavoronkovSeptember 9, 2024
LeadershipThe Fortune 500 is built on more than money. It’s built on human, social, and natural capital, too
By Andre Hoffmann and Peter VanhamSeptember 6, 2024
By Sanne Wass and BloombergSeptember 3, 2024
HealthNew COVID vaccines are here. What to know about latest shots in wake of nation’s biggest summer surge
By Lindsey LeakeAugust 29, 2024
By Andrei Iancu and David J. KapposAugust 28, 2024
FinanceNovo Nordisk’s weight-loss drugs and Bavarian Nordic’s mpox vaccine help fatten up the Danish economy
By Sanne Wass and BloombergAugust 20, 2024
TechThis startup believes shopping around for prescription drugs should be as easy as shopping on Amazon. The future of a $700 billion industry is at stake
By Jason Del ReyAugust 15, 2024
Most Popular
